My clinical service and academic interests focus on implementing new tests for in vitro diagnosis and to improve quality of testing by promoting excellence in automation, toxicology and point of care areas of laboratory.

Dr. Budelier is an Instructor in Pathology and Immunology at Washington University in St Louis, and is a Co-Medical Director of the Barnes Jewish Hospital Toxicology Laboratory. Her research interests are broadly focused on developing clinically useful, mass spectrometry-based assays to improve diagnosis and treatment of human disease. Her expertise are in Toxicology/TDM, assay development and validation, and protein quantification.

Dustin R. Bunch, is an Asst. Director of Clinical Chemistry & Laboratory Informatics at Nationwide Children's Hospital. His research focuses small molecule analysis by mass spectrometry in a clinical setting and hospital and clinical informatics.

Pankaj has expertise in cancer biology, quantitative proteomics-phosphoproteomics, protein biochemistry, and proteomics data analysis. He has published seminal scientific papers on the cytokine receptor biology and its role in leukemia. His sphere of experience and interest includes but not limited to cell cultures, mouse models, processing proteomics samples and operating nano-LC-MS/MS. He has in-depth knowledge and understanding of quantitative proteomics techniques, e.g. SILAC, TMT, iTRAQ and RABA and understanding of aberrant proteomics as well as phospho-signaling and global ubiquitin profiles of solid and liquid tumor models.

Currently a PhD candidate, at Imperial College London, specialising in the metabolomic and microbiomic stratification of Inflammatory Bowel Disease (IBD) patients (both Crohn's and Ulcerative Colitis). Some of my skills include biological/clinical sample preparation and analysis using LC-MS, GC-MS, and proton NMR, and the processing of metabolomic data following acquisition. I have a personal interest in scientific writing and communication.

Oleg Karaduta holds faculty position at University of Arkansas for Medical Sciences. His research focuses on development of mass spectrometry-based proteomics tools for the analysis of protein-protein interaction networks and for metaproteomics.

I have obtained a degree as an Engineer in Chemistry focusing on analytical biochemistry, followed by a masters and PhD in Biochemistry (SS Cyril and Methodius University, N Macedonia) with a major focus on clinical proteomics and MALDI mass spectrometry. I have furthered my experience in a clinical laboratory (Clinic of Neurology), academia (The Biodesign Institute, ASU) and Industry (HealthTell Inc ). I am fascinated by mass spectrometry and the unambiguity it possess. I am currently a Senior Scientist at Cowper Sciences Inc, where I am focusing on exploring/applying novel methods and techniques in proteomics research, with potential for operation and commercialization.